FBRX

Forte Biosciences
FBRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$48.33M
EV
$-10.04M
Shares Outstanding
6.58M
Beta
2.86

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$59.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Forte Biosciences, Inc.

gainify
FBRX

Forte Biosciences, Inc.

FBRX

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is h...

Sector

Healthcare

Industry

Biotechnology

CEO

Wagner, Paul A.

Employees

14

IPO Date

2017-04-13

Headquarters

3060 Pegasus Park Drive, Building 6, Dallas, Texas, 75247, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved